What is the ENT Handheld Instruments Market Analysis?

 

ENT Handheld Instruments Market by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World). 

 

In the product segment of the ENT Handheld Instruments Market, the otology instruments category is estimated to hold a significant share in the forecast period.  This can be ascribed to the rising prevalence of ear-related ailments such as age- related hearing loss in elderly, otitis media particularly in pediatric population, cases of vertigo and dizziness, and tinnitus among others compared to indications associated with rhinology and laryngology.  Therefore, the increase in the prevalence of ear-related ailments are expected to drive the demand for otology-related handheld devices, which in turn would result in the growth of the overall the ENT handheld instruments market during the forecast period (2021-2026).

 

North America is expected to dominate the Overall ENT Handheld Instruments Market Forecast

 

Among all the regions, North America is expected to account for the largest share in the ENT handheld instruments market. Owing to significant growth factors such as surging cases of obstructive sleep apnea, increasing prevalence of sinusitis, increasing geriatric population, and rising government initiatives for creating awareness regarding hearing loss prevalence and treatment are expected to aid in the growth of the North America ENT Handheld Instruments Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region. 

 

As per the data provided by the Centers for Disease Control and Prevention (CDC) in 2020, near about 28.9 million adults were diagnosed with sinusitis in the United States. Moreover, the information provided by the World Allergy Organization (2021), the prevalence of chronic sinusitis is usually in the range of 12% in the United States. Chronic sinusitis can cause major trouble in breathing and sinus surgery is often recommended in patients that are refractory to medications and other therapies. Therefore, with the presence of high patient pool of chronic sinusitis patients in the country, it is estimated that there may be an increase in the number of procedures of sinus surgery being performed that may in turn drive the demand for ENT handheld instruments, thereby supporting the growth of the United States ENT handheld instruments market during the forecast period.

 

Furthermore, according to the American Sleep Apnea Association (2021), currently an estimated number of 22 million Americans suffer from obstructive sleep apnea.  Even though positive airway pressure (PAP) therapy is the gold standard OSA treatment, it has been observed that the patient compliance with PAP therapy can be low due to various factors as well as PAP therapy being ineffective in other set of patients. Therefore, in such patients, surgeries are recommended which are focused on correcting the structural defects in the nose, throat, and upper respiratory tract. Thus, owing to the increasing prevalence of OSA in the country, the demand for ENT handheld instruments may witness an increase in the United States, resulting in the growth of the United States ENT handheld instruments market as well as the North America ENT handheld instruments market.

 

What are the ENT Handheld Instruments Market Companies?

 

Some of the key market players operating in the ENT handheld instruments market includes Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated and others.